12:00 AM
 | 
Nov 15, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Silence Therapeutics preclinical data

In mouse models of lung cancer metastasis, IV Atu027 significantly inhibited the formation of spontaneous pulmonary metastasis vs. control...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >